市場調查報告書
商品編碼
1489436
到 2030 年食品診斷市場預測:按類型、測試類型、診斷系統、地點、污染物類型、應用和地區進行的全球分析Food Diagnostics Market Forecasts to 2030 - Global Analysis By Type (Systems, Consumables and Other Types), Testing Type (Safety and Quality), Diagnostics System, Site, Contaminant Type, Application and by Geography |
根據 Stratistics MRC 的數據,2023 年全球食品診斷市場規模為 165 億美元,預計在預測期內將以 9.70% 的複合年成長率成長,到 2030 年達到 315.5 億美元。
為了確保食品安全和質量,食品診斷是一個重要領域,涉及食品中污染物、病原體和其他物質的檢測和分析。利用 DNA 分析、層析法和光譜等先進方法,研究人員可以檢測過敏原、農藥、細菌和毒素等可能的危害。此外,快速、準確的食品診斷對於避免食品感染疾病、確保法規遵循和保護公眾健康至關重要。
據美國心臟協會稱,定期運動有助於控制血脂、血壓和體重,預防心臟病、中風、糖尿病和某些癌症,增強骨骼和肌肉,改善心理健康,提高幸福感。
食物中毒事件呈上升趨勢
隨著世界人口的成長和都市化,食品和加工食品的消費量不斷增加。不幸的是,這種趨勢也增加了細菌、病毒和寄生蟲等病原體污染食品而導致食源性疾病的發生率。此外,現在比以往任何時候都更需要高效的食品診斷解決方案,以便在受污染的商品出售給客戶之前識別並減少可能的風險。
尖端診斷工具成本高
雖然技術進步正在創造日益複雜和精確的食品診斷技術,但這些尖端工具通常價格昂貴。對於小型食品公司和實驗室來說,實施先進診斷設備和系統所需的初始投資可能令人望而卻步。此外,由於持續維護、校準和培訓成本等額外的財務負擔,這些技術尚未被廣泛採用,特別是在新興經濟體和小型食品企業中。
新興市場和食品產業的快速發展
由於都市化、人口成長和消費者偏好變化等多種因素,食品工業正在世界各地迅速擴張。亞太地區、拉丁美洲和非洲是食品診斷產業具有巨大成長潛力的新興市場。此外,這些地區的經濟成長和都市化正在增加食品的需求,因此需要強力的食品安全和品質保證解決方案。
市場進入障礙和監管合規性
由於監管機構執行嚴格的法規和標準,食品診斷公司在擴大業務和進入新市場方面面臨挑戰。食品製造商和診斷服務提供者因遵守不斷變化的法律規範(包括食品安全、品質標準和標籤要求)而承受巨大的財務和資源成本。此外,由於不同地區和國家的監管要求不同且不一致,國際貿易和市場進入變得更加複雜。
食品診斷市場受到了 COVID-19 大流行的各種影響。一方面,對食品安全和衛生的日益重視增加了對診斷工具的需求,以確保食品品質和安全。監管機構、食品製造商和食品加工商正在加強測試和監測計劃,以識別可能的污染物並阻止病毒透過食品傳播。然而,疫情擾亂了供應鏈,導致物流問題、勞動力短缺和生產延誤,從而影響了食品診斷用品和服務的可用性和可及性。
基於免疫檢測的細分市場預計將在預測期內成為最大的細分市場
食品診斷市場預計將由基於免疫檢測的診斷領域主導。基於免疫檢測的技術依賴抗體與目標分析物的特異性結合,在食品安全實驗室和食品生產設施的常規測試中很普及。其他優點包括高靈敏度、快速結果和易於使用。基於免疫測量的套件和平台廣泛用於篩檢食品中的各種危害,包括微生物病原體、毒素、農藥和過敏原。
預計病原體產業在預測期內複合年成長率最高
食品診斷市場的病原體診斷部分預計將以最高複合年成長率成長。病原體診斷的作用是檢測可能導致經由食物傳染疾病的危險細菌、病毒和寄生蟲,對於維護食品安全至關重要。食物中毒患者數量的增加以及對食品安全的日益關注增加了對快速、準確檢測食品中病原體的方法的需求。此外,由於次世代定序(NGS)、免疫測量和聚合酵素鏈鎖反應(PCR)等先進的分子診斷技術,病原體檢測正在經歷一場革命,比傳統的基於培養的方法具有更高的靈敏度、特異性和速度。
食品診斷市場由北美主導。該地區的主導地位歸因於多種因素,包括重要的市場參與者和研究機構的存在、嚴格的食品安全法規以及先進的醫療基礎設施。美國農業部 (USDA) 和食品藥物管理局(FDA) 制定了嚴格的標準和法規來確保食品安全和質量,這推動了對先進食品診斷技術的需求。此外,食源性疾病發生率的上升和消費者食品安全意識的提高也推動了該地區先進診斷解決方案的採用。
食品診斷市場正以亞太地區最高的複合年成長率成長。推動這一成長的因素有很多,包括人口擴張、快速都市化、可支配收入增加以及食品安全法的變化。隨著消費者健康意識的增強並要求更安全的食品,對強大的食品診斷解決方案的需求日益成長,以確保整個供應鏈的食品安全和品質。此外,該地區食品加工業的成長、食品貿易的全球化以及食源性疾病的增加正在推動先進診斷技術的採用。
According to Stratistics MRC, the Global Food Diagnostics Market is accounted for $16.50 billion in 2023 and is expected to reach $31.55 billion by 2030 growing at a CAGR of 9.70% during the forecast period. In order to guarantee food products' safety and quality, food diagnostics is an important field that involves the detection and analysis of contaminants, pathogens, and other substances in food products. By utilizing sophisticated methods like DNA analysis, chromatography, and spectroscopy, researchers can detect possible dangers such as allergens, pesticides, bacteria, and toxins. Moreover, quick and precise food diagnostics are essential for avoiding food borne infections, upholding legal compliance, and protecting the general public's health.
According to the American Heart Association, Regular physical activity helps control blood lipids, blood pressure, and weight; prevents heart disease, stroke, diabetes, and some types of cancer; strengthens bones and muscles and improves psychological well-being.
Growing number of food borne illnesses
The consumption of packaged and processed foods has increased in tandem with the growth in the world's population and urbanization. Unfortunately, as a result of pathogens like bacteria, viruses, and parasites contaminating food products, this trend has also increased the frequency of foodborne illnesses. Additionally, as a result, there is a greater need than ever for efficient food diagnostic solutions to recognize and reduce possible hazards before tainted goods are sold to customers.
High expenses of cutting-edge diagnostic tools
While improvements in technology have resulted in the creation of increasingly complex and precise food diagnostic techniques, these state-of-the-art tools are frequently expensive. Smaller food businesses and laboratories may find it prohibitive to make the initial investment necessary for acquiring and implementing advanced diagnostic equipment and systems. Furthermore, these technologies are not widely adopted, especially in emerging economies and small-scale food enterprises, due to additional financial burdens such as ongoing maintenance, calibration, and training costs.
Rapid development in emerging markets and the food sector
The food industry is expanding rapidly worldwide due to various factors like urbanization, population growth, and shifting consumer preferences. Asia-Pacific, Latin America, and Africa are among the emerging markets that offer substantial potential for the food diagnostics industry to grow. Moreover, strong food safety and quality assurance solutions are required as these areas experience economic growth and urbanization due to the rising demand for packaged and processed foods.
Barriers to market access and regulatory compliance
Food diagnostic companies face challenges in expanding their operations and entering new markets due to strict regulations and standards enforced by regulatory bodies. Food manufacturers and diagnostic service providers bear heavy financial and resource costs as a result of complying with various and changing regulatory frameworks, such as those pertaining to food safety, quality standards, and labeling requirements. Additionally, international trade and market access are further complicated by regional and national regulatory requirements that differ and are inconsistent.
The food diagnostics market has been impacted by the COVID-19 pandemic in a number of ways. On the one hand, there is a greater need for diagnostic tools to guarantee the quality and safety of food products due to the growing emphasis on food safety and hygiene. Regulatory bodies, food producers, and food processors have stepped up testing and observation programs to find possible contaminants and stop the virus from spreading through food. However, the pandemic has caused supply chain disruptions, which have impacted the availability and accessibility of food diagnostic goods and services by creating logistical problems, a labor shortage, and production delays.
The Immunoassay Based segment is expected to be the largest during the forecast period
The market for food diagnostics is expected to be dominated by the immunoassay-based diagnostics segment. Immunoassay-based techniques, which rely on the specific binding of antibodies to target analytes, are popular for routine testing in food safety laboratories and food production facilities. Furthermore, they offer advantages like high sensitivity, rapid results, and ease of use. Immunoassay-based kits and platforms are widely used for screening food products for various hazards, including microbial pathogens, toxins, pesticides, and allergens.
The Pathogens segment is expected to have the highest CAGR during the forecast period
The food diagnostics market's pathogen diagnostics segment is projected to grow at the highest CAGR. Detecting dangerous bacteria, viruses, and parasites that can lead to food borne illnesses is what pathogen diagnostics do, and it is essential to maintaining food safety. The need for quick and precise ways to find pathogens in food products has increased due to the rise in foodborne illness cases and growing worries about food safety. Moreover, pathogen detection has undergone a revolution thanks to advanced molecular diagnostic techniques like Next-Generation Sequencing (NGS), immunoassays, and polymerase chain reaction (PCR), which offers higher sensitivity, specificity, and speed than conventional culture-based methods.
The market for food diagnostics is dominated by North America. The region's dominance is ascribed to multiple factors, such as the existence of important market players and research institutions, strict regulations pertaining to food safety, and sophisticated healthcare infrastructure. The United States Department of Agriculture (USDA) and the Food and Drug Administration (FDA) enforce strict standards and regulations to guarantee the safety and quality of food products, which fuels the demand for advanced food diagnostic technologies. Additionally, the adoption of advanced diagnostic solutions in the region has also been fueled by rising foodborne illness incidence and heightened consumer awareness of food safety.
The market for food diagnostics is growing at the highest CAGR in the Asia-Pacific region. Numerous factors are driving this growth, such as population expansion, fast urbanization, rising disposable incomes, and changing food safety laws. Robust food diagnostic solutions are becoming increasingly necessary to guarantee food safety and quality throughout the supply chain as consumers become more health-conscious and demand safer food products. Furthermore, the region's adoption of advanced diagnostic technologies is being propelled by the growth of the food processing industry, the globalization of food trade, and the increasing prevalence of foodborne illnesses.
Key players in the market
Some of the key players in Food Diagnostics market include Biomerieux Sa, Thermo Fisher Scientific Inc., Merck KGaA, Danaher Corporation, 3M Company, Randox Food Diagnostics, Shimadzu Corporation, Bio-Rad Laboratories, Inc., Neogen Corporation, Ring Biotechnology Co Ltd., Agilent Technologies Inc., Nemis Technologies AG, Clear Labs, Inc., PerkinElmer Inc. and Biorex Food Diagnostics.
In April 2024, Merck KGaA Darmstadt, Germany entered into a licensing agreement with Inspirna, Inc. for ompenaclid (RGX-202), a first-in-class oral inhibitor of the creatine transport channel SLC6A8, and SLC6A8-targeting follow-on compounds. Ompenaclid is currently being evaluated in a Phase II study for the second-line treatment of RAS-mutated (RASmut) advanced or metastatic colorectal cancer (mCRC).
In October 2023, To support emerging precision therapies and improve patient outcomes by increasing access to reliable genomic testing needed to match patients with targeted cancer treatments, Thermo Fisher Scientific today announced a companion diagnostic (CDx) partnership with Boehringer Ingelheim. Through this collaboration, the companies will work to develop CDx tests to help identify patients with non-small cell lung cancer (NSCLC) with specific genomic mutations.
In August 2023, Science and medical technology firm Danaher announced that it has entered into an agreement to acquire Abcam, a Cambridge, U.K.-based supplier of antibodies, reagents, biomarkers, and assays. Under the agreement, Danaher will acquire all outstanding Abcam shares for $24 per share in cash, with a total enterprise value of approximately $5.7 billion, including Abcam's assumed debts and net of acquired cash.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.